Methylnaltrexone (Relistor) for opioid-induced constipation

Mark Abramowicz, Gianna Zuccotti, Jean Marie Pflomm, Susan Morey, Eric J. Epstein, Philip D. Hansten, Jules Hirsch, David N. Juurlink, Richard B. Kim, Gerald L. Mandell, Hans Meinertz, Dan M. Roden, F. Estelle R. Simons, Neal H. Steigbigel, Donna Goodstein, Amy Faucard, Cynthia Macapagal Covey, Lauren K. Schwartz, Cheryl Brown, Liz DonohueSusie Wong, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort survey

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)63-64
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume50
Issue number1292
StatePublished - Aug 11 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abramowicz, M., Zuccotti, G., Pflomm, J. M., Morey, S., Epstein, E. J., Hansten, P. D., Hirsch, J., Juurlink, D. N., Kim, R. B., Mandell, G. L., Meinertz, H., Roden, D. M., Simons, F. E. R., Steigbigel, N. H., Goodstein, D., Faucard, A., Covey, C. M., Schwartz, L. K., Brown, C., ... Wissner-Levy, Y. (2008). Methylnaltrexone (Relistor) for opioid-induced constipation. Medical Letter on Drugs and Therapeutics, 50(1292), 63-64.